Dapsone and pregnancy: what's actually safe to use

Last updated 2026-07-30

Is dapsone safe during pregnancy?

It depends entirely on which dapsone you mean, and that's the confusion that trips people up. Topical dapsone gel (brand name Aczone, 5% or 7.5%) is FDA-approved for acne and sits in a different risk category than oral dapsone tablets, which are prescribed for conditions like dermatitis herpetiformis, leprosy, and Pneumocystis pneumonia prophylaxis. Topical Aczone is classified FDA Pregnancy Category C. That means animal studies have shown some risk or no adequate studies exist in humans, and the drug should be used only if the potential benefit justifies the potential risk to the fetus ^[1]. In practice, systemic absorption of topical dapsone gel is low. Studies measuring plasma levels after topical application found dapsone concentrations far below what you'd see with an oral dose, which is the whole reason dermatologists consider it a reasonably low-risk option during pregnancy compared to the pill form ^[2]. Oral dapsone is another story. It crosses the placenta, it's been linked to neonatal hemolytic anemia and methemoglobinemia, and its use in pregnancy is generally reserved for situations where there's no good alternative, like severe dermatitis herpetiformis that isn't controlled by diet alone. If you're pregnant and your doctor has you on oral dapsone, that's a decision that should involve a maternal-fetal medicine specialist, more than your regular dermatologist. So the short version: topical, probably fine, discuss with your OB. Oral, needs real specialist oversight and G6PD testing before you even start.

What does the FDA pregnancy category actually mean for topical dapsone gel?

Category C is not a green light, it's a shrug with data behind it. The FDA's older pregnancy categories (A, B, C, D, X) have technically been phased out for new drug labeling since 2015 under the Pregnancy and Lactation Labeling Rule, but Aczone's label and most reference materials still cite the Category C designation from when it was reviewed ^[3]. Category C historically meant one of two things: animal reproduction studies showed an adverse effect on the fetus, or no animal or human studies were done at all, and the drug is approved anyway because doctors judged the benefit could outweigh the risk on a case by case basis. For Aczone specifically, the original FDA-approved labeling notes that oral dapsone studies in animals showed no evidence of fetal harm at certain doses, but adequate, well-controlled studies in pregnant women haven't been done for the topical formulation ^[1]. What matters practically is exposure. A 2012 pharmacokinetic study looking at dapsone gel 5% found that plasma concentrations after topical use were roughly 1% of the levels seen with oral dapsone dosing for dermatitis herpetiformis, meaning the systemic dose your body (and a developing fetus) would actually see is a small fraction of what oral therapy delivers ^[2]. That's the number dermatologists lean on when they say topical dapsone is 'probably lower risk' during pregnancy. It's reassuring, but it's not the same as a clinical trial in pregnant women, because that trial doesn't exist and likely never will for ethical reasons.

Can you use Aczone (topical dapsone) while pregnant?

Many dermatologists will continue or start topical dapsone gel during pregnancy for acne, but this should be a conversation with your OB or midwife first, not a solo decision based on a drugstore label. The practical reasoning goes like this: acne during pregnancy is common, hormonally driven, and genuinely distressing for a lot of people, but most first-line pregnancy-safe options (topical azelaic acid, some topical erythromycin or clindamycin) get tried before dapsone gel because they have more established safety records. If those don't work well enough, some clinicians are comfortable adding topical dapsone given the low absorption data. Things that would make a doctor say no or pause: any personal or family history of G6PD deficiency, since even the small systemic absorption from topical use is a theoretical concern in someone who's G6PD deficient. There's no requirement for G6PD testing before topical dapsone the way there is for oral, but if you already know you're G6PD deficient, mention it. This is exactly the kind of nuance that gets lost online, where 'dapsone during pregnancy' searches surface warnings written about the oral drug and scare people off a topical product with a very different risk profile. If you're weighing whether topical dapsone is worth starting at all, right now or postpartum, the dapsone pros and cons breakdown and is dapsone worth it piece cover the acne-specific tradeoffs outside of pregnancy.

What are the risks of oral dapsone during pregnancy?

Oral dapsone's risks in pregnancy come from the same mechanism that makes it work: it oxidizes hemoglobin and stresses red blood cells, and a fetus and newborn have less reserve to handle that than an adult does. The documented concerns include neonatal hemolytic anemia and methemoglobinemia in infants exposed to dapsone late in pregnancy or through breast milk after delivery. Case reports and small case series describe hemolytic anemia in newborns whose mothers took oral dapsone for dermatitis herpetiformis through pregnancy, and pediatric guidance generally recommends caution with dapsone exposure in the third trimester and during breastfeeding ^[4]. Dapsone also crosses into breast milk. The National Institutes of Health's LactMed database notes that infants of mothers taking dapsone should be monitored for signs of hemolysis (pallor, jaundice, poor feeding) especially if the infant has G6PD deficiency or is premature, and some sources recommend against breastfeeding during oral dapsone therapy or suggest monitoring the infant closely if it's continued ^[5]. None of this means oral dapsone is never used in pregnancy. Dermatitis herpetiformis that's refractory to a strict gluten-free diet sometimes has no better option, and untreated severe DH has its own burden. But that calculation belongs to a specialist team, not a general risk-benefit guess.

Why does G6PD deficiency matter so much with dapsone in pregnancy?

G6PD (glucose-6-phosphate dehydrogenase) deficiency is a genetic condition that leaves red blood cells more vulnerable to oxidative damage, and dapsone is a classic oxidative-stress drug. In someone who's G6PD deficient, oral dapsone can trigger acute hemolytic anemia, sometimes severe enough to need transfusion. This matters twice over in pregnancy: the mother's own G6PD status affects her hemolysis risk on the drug, and the fetus can inherit G6PD deficiency too (it's X-linked, so it disproportionately affects male fetuses). A newborn with G6PD deficiency who was exposed to dapsone in utero or through breast milk is at meaningfully higher risk of neonatal hemolysis and jaundice. CDC and standard hematology references list G6PD deficiency as one of the most common enzyme deficiencies worldwide, with higher prevalence in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, which is part of why G6PD testing before starting oral dapsone is considered standard of care, pregnant or not ^[6]. If you're pregnant and being considered for oral dapsone, G6PD testing (yours, and sometimes genetic counseling about the fetus) should happen before the first dose, not after a hemolytic episode.

What other serious risks does oral dapsone carry, pregnant or not?

Oral dapsone's side effect profile is the reason it's not handed out casually for acne, in pregnancy or otherwise. This is a sulfone antibiotic, not a topical gel, and the differences matter. Beyond hemolysis, oral dapsone carries risk of methemoglobinemia (a blood disorder where hemoglobin can't release oxygen properly, causing symptoms like shortness of breath, bluish skin, and fatigue), agranulocytosis (a dangerous drop in infection-fighting white blood cells, described in the drug's prescribing information as a rare but serious risk requiring blood count monitoring), and dapsone hypersensitivity syndrome, a delayed reaction that can include fever, rash, and organ involvement, typically appearing 2 to 6 weeks after starting the drug ^[7]. These risks exist independent of pregnancy, but pregnancy adds a second patient to worry about. A hemolytic episode or methemoglobinemia in the mother reduces oxygen delivery to the fetus at the exact time oxygen delivery matters most. This is a core reason oral dapsone isn't a drug anyone should start for acne. Topical Aczone exists specifically because dermatologists wanted dapsone's anti-inflammatory acne benefit without the systemic sulfone exposure and its monitoring burden ^[1].

Does dapsone affect fertility or the ability to get pregnant?

There's no strong evidence that either topical or oral dapsone affects fertility in men or women at standard doses. This isn't a heavily studied question, so the honest answer is that the data is thin rather than reassuring, but nothing in the FDA labeling or major case series flags fertility impairment as a known effect ^[1]. What's more relevant for someone trying to conceive is timing around starting or stopping the drug. If you're on oral dapsone for a chronic condition and are planning pregnancy, that's worth a pre-conception conversation with your prescriber, both for G6PD testing (if not already done) and for reviewing whether the dose or drug needs adjusting before you conceive. For topical dapsone and acne, there's generally no need to stop before trying to conceive, though again, loop in your OB once you're pregnant.

Is dapsone safe while breastfeeding?

Topical dapsone gel and oral dapsone tablets are handled very differently here too, and this is where a lot of postpartum patients get conflicting advice. For oral dapsone, the LactMed database (part of the National Library of Medicine) states that dapsone passes into breast milk, and infants exposed through breastfeeding have developed hemolytic anemia, particularly at higher maternal doses or in G6PD-deficient infants. Some clinicians recommend monitoring the infant's blood counts if the mother continues oral dapsone while breastfeeding, and others recommend avoiding it or timing feeds around dosing ^[5]. For topical dapsone gel, the systemic absorption is low enough that many dermatologists consider it compatible with breastfeeding, similar to the pregnancy reasoning, but there isn't a large dedicated study confirming this for lactation specifically. If you're breastfeeding and using Aczone for acne, mention it at a pediatric visit so it's on record, even if your dermatologist and OB are both comfortable with it.

How is topical dapsone different from oral dapsone, and why does that distinction matter here?

This is the single most important thing to understand before searching 'dapsone and pregnancy' one more time, because most of the scary information you'll find online is about the oral drug, not the acne gel. | | Topical dapsone (Aczone gel) | Oral dapsone (tablets) |

What should you do if you're pregnant and currently using dapsone?

Call your prescriber, don't just stop cold on your own, and be specific about which form you're using. That one sentence covers most of what actually matters here. If you're using topical Aczone for acne and just found out you're pregnant, most dermatologists will have you continue or discontinue based on your specific acne severity and preference, since the absorption data is reassuring even if not conclusive ^[2]. There's rarely urgency to stop mid-cycle. If you're on oral dapsone for dermatitis herpetiformis or another condition and become pregnant, that's a call to make sooner rather than later, ideally within days, so your specialist team (dermatology plus maternal-fetal medicine) can review your G6PD status, current dose, and trimester-specific plan. Abruptly stopping oral dapsone for a condition like DH can cause a flare, so this needs a managed transition, not a cold stop. Either way, don't rely on a pharmacy insert or a forum thread to make this call. If you're deciding whether to start dapsone for acne at all and pregnancy is somewhere in your plans in the next year, that's worth raising up front with a provider, and a provider-reviewed telehealth path (Dapsone Rx works with a licensed pharmacy partner to fill prescriptions after appropriate provider review) is a reasonable way to get that conversation started without a long wait for an in-person dermatology appointment.

What does the acne evidence say about dapsone gel outside of pregnancy?

Since a lot of readers land here while deciding whether dapsone gel is worth trying in the first place, it's worth knowing where it sits in the acne evidence, separate from the pregnancy question entirely. Aczone 7.5% gel, the once-daily formulation, was evaluated in two 12-week randomized controlled trials with roughly 4,340 participants, where investigators found statistically significant reductions in inflammatory and noninflammatory acne lesions versus vehicle gel ^[1]. It's not considered as potent as benzoyl peroxide or tretinoin as monotherapy for many patients, and it works best as an add-on, particularly for people with sensitive skin or inflammatory acne who don't tolerate stronger retinoids well. If you're trying to figure out whether it's worth the cost and the daily routine, the dapsone success rate and dapsone results timeline pages go through the trial data and realistic expectations in more depth, and dapsone before and after covers what changes people actually report and on what timeline. None of that evidence changes because you're pregnant, but the decision of whether to start now versus wait does deserve its own conversation with your OB.

Frequently asked questions

Can I use Aczone (topical dapsone) if I'm pregnant?

Many dermatologists are comfortable continuing or starting topical dapsone gel during pregnancy because systemic absorption is low, roughly 1% of oral dosing levels in pharmacokinetic studies. It's FDA Pregnancy Category C, meaning it isn't proven safe but isn't flagged as clearly harmful either. Talk to your OB before starting or continuing, especially if you have any personal or family history of G6PD deficiency.

Is oral dapsone safe during pregnancy?

Oral dapsone is used in pregnancy only when there's no good alternative, typically for dermatitis herpetiformis unresponsive to diet. It carries documented risk of neonatal hemolytic anemia and methemoglobinemia, and requires G6PD testing and specialist monitoring throughout pregnancy. This isn't a decision to make without a maternal-fetal medicine specialist involved.

What is G6PD deficiency and why does it matter for dapsone?

G6PD deficiency is a genetic enzyme deficiency that makes red blood cells vulnerable to oxidative damage. Dapsone is an oxidative-stress drug, so G6PD-deficient people risk acute hemolytic anemia on oral dapsone. It's X-linked and more common in people of African, Mediterranean, and Southeast Asian descent, which is why G6PD testing is standard before starting oral dapsone.

Can dapsone cause birth defects?

There's no strong evidence linking topical or oral dapsone to structural birth defects specifically. The documented risks are hemolytic anemia and methemoglobinemia in the fetus or newborn from oral dapsone exposure, not congenital malformations. Topical dapsone's low systemic absorption further limits fetal exposure, though a large dedicated human safety study doesn't exist.

Does dapsone pass into breast milk?

Oral dapsone does pass into breast milk and has caused hemolytic anemia in breastfed infants, according to the NIH's LactMed database. Topical dapsone gel's low absorption makes it more likely compatible with breastfeeding, though dedicated lactation studies are limited. Mention any dapsone use to your pediatrician regardless of form.

Should I stop dapsone if I just found out I'm pregnant?

Don't stop on your own, call your prescriber first. If you're using topical Aczone, most dermatologists see no urgent need to stop and will discuss continuing based on your acne severity. If you're on oral dapsone for a condition like dermatitis herpetiformis, your specialist needs to manage any transition since stopping abruptly can cause a flare.

Do I need a G6PD test before using dapsone gel for acne?

G6PD testing isn't routinely required before topical dapsone gel because systemic absorption is low. It is standard of care before starting oral dapsone, pregnant or not, since G6PD-deficient people risk serious hemolysis on the oral drug. If you already know you're G6PD deficient, tell your dermatologist before starting either form.

What is dapsone hypersensitivity syndrome?

Dapsone hypersensitivity syndrome is a rare but serious delayed reaction to oral dapsone, typically appearing 2 to 6 weeks after starting the drug, that can include fever, rash, and organ involvement. It's one of the reasons oral dapsone requires close monitoring and isn't used casually, in pregnancy or otherwise.

Is topical dapsone the same drug as oral dapsone?

Chemically, yes, both contain dapsone, but the formulation and exposure are very different. Topical gel delivers a small fraction of the systemic dose that oral tablets do, which is why the two have very different risk profiles, monitoring requirements, and FDA-approved uses.

Can men on dapsone affect a pregnancy through sperm?

There's no established evidence that dapsone in a male partner affects fertility or fetal outcomes through sperm exposure. This hasn't been a major focus of research, so the honest answer is that data is limited rather than definitively reassuring, but it isn't flagged as a known risk in current prescribing information.

Why do pregnancy warnings for dapsone seem so different online?

Most alarming information about dapsone and pregnancy describes the oral drug's risks (hemolysis, methemoglobinemia), which get mistakenly applied to topical Aczone gel. The two have very different absorption levels and risk profiles. Always check whether a source is discussing oral tablets or topical gel before applying the warning to your situation.

Can dapsone cause a miscarriage?

There's no established data showing topical or oral dapsone directly causes miscarriage. The documented pregnancy risks relate to hemolytic anemia and methemoglobinemia in a fetus or newborn exposed to oral dapsone, not pregnancy loss specifically. If you're pregnant and worried about a specific symptom, contact your OB rather than guessing from the drug label.

Sources

1. FDA, Aczone (dapsone) Gel prescribing information: Aczone is FDA-approved for acne, classified Pregnancy Category C, and trial data on lesion reduction
2. Piette et al., Journal of Drugs in Dermatology, dapsone gel pharmacokinetics: Topical dapsone gel systemic absorption is roughly 1% of oral dapsone plasma levels
3. FDA, Pregnancy and Lactation Labeling Rule (PLLR): FDA phased out letter pregnancy categories (A,B,C,D,X) for new drug labeling starting in 2015
4. National Library of Medicine, case literature on dapsone in dermatitis herpetiformis and pregnancy: Neonatal hemolytic anemia has been reported in infants exposed to oral dapsone during pregnancy
5. NIH LactMed, Dapsone: Dapsone passes into breast milk and has caused hemolytic anemia in breastfed infants
6. CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency is a common X-linked enzyme deficiency with higher prevalence in certain populations
7. FDA, Dapsone tablets prescribing information: Oral dapsone carries risk of agranulocytosis, methemoglobinemia, and dapsone hypersensitivity syndrome, and requires G6PD testing